![]() |
Urology Nurses Online: ARTICLES |
April 1998
Karen Kaufmann Rauen, MSN, RN
St. Michael Hospital
Spina Bifida Center, Nurse Manager
Milwaukee, Wisconsin
Trudi Biefeld, BSPA, RN
St. Michael Hospital
Spina Bifida Center, Staff Nurse III
Milwaukee, Wisconsin
Anthony H. Balcom, MD, FAAP
Children's Hospital of Wisconsin
St. Michael Hospital Spina Bifida Center
Medical Advisor, Bladder Therapies
Milwaukee, Wisconsin
Have you thought about using or developing continence assessment tools
to track treatment outcomes for your patients? Are measurement tools in the literature
inadequate for your purposes? Would you be interested in easy to use assessment/documentation
tools you could start using now? If you answered "yes" to any of the above
questions, the information provided in this article about new continence tools and
tool development, could be very useful in your clinical practice and in designing
your own tools. Particularly, this article discusses the process of tool development,
the importance of tool validity and reliability, when and how to get help with tool
design, and the impact proper documentation tools have on continence therapies.
CONTINENCE PROGRAM DEVELOPMENT
A new Spina Bifida Continence Program was developed in 1994 at the Spina Bifida Center,
St. Michael Hospital, Milwaukee, Wisconsin. The program objective was improvement
of urinary and fecal continence in people with myelomeningocele. Incontinence is
a lifelong challenge for many in this population. The three primary components of
the Continence Program were: Continence Coaching; Therapeutic Electrical Stimulation
(TES) Therapy; and Neuromuscular Re-education (biofeedback).
"Continence Coaching" is the active process of: (1) determining a patient's
elimination habits and patterns, (2) identifying the changes needed to improve function,
and (3) after exploring options to achieve the changes, choosing an appropriate treatment
plan. Following implementation of the treatment plan and a reasonable amount of time
for improvement to occur, outcomes should be assessed and documented. The treatment
plan is then continued or revised, based on the outcomes.
TES is a home treatment administered to a child at night while the child sleeps.
Two sets of electrodes are placed on the skin in specific areas at bedtime. A pocket-sized
stimulator is set to deliver a low level of electrical stimulation intermittently
throughout the night. Left and right side electrode placement is alternated six out
of seven consecutive nights. The intent is to provide a low level of stimulation
to muscles and nerves involved with continence, and to reverse any disuse muscle
atrophy. Follow-up occurs at six-month intervals to evaluate progress towards specific
continence goals.
Neuromuscular re-education is instituted to teach the child how to control the muscles
involved with continence, when those muscles have been strengthened. It is the final
component of the Spina Bifida Continence Program. Again, at regular intervals, progress
towards specific continence goals is evaluated.
Depending on diagnosis and circumstances, these primary components may be used independently
or collectively. Evaluation tools to assess and document clinical outcomes and progress
towards goals are essential to each component.
CONTINENCE ISSUES ARE COMPLEX
Continence issues are complex, highly individualized, and influenced by many variables.
Assessment and documentation of a patient's continence status must address the variables
relevant to that patient. For example, dietary habits, exercise, medications, time
of meals, type of clothing, cognitive abilities, sensation level, and degree of independent
functioning may all affect continence. Use of protective pads is another example.
The number of pads used a day, type of absorbency, and degree of saturation all need
to be considered. Another variable is the need to change clothing due to incontinence.
Frequency of change, time of change, and whether the change is due to urine, feces,
or both, need to be determined.
IN SEARCH OF TOOLS
Quality measurement tools - those that assess and document functional characteristics
related to continence - need to be applied before interventions are started, as well
as after, to determine effectiveness of the interventions. Useful measurement tools
have several key characteristics. The tools need to be: 1) clear in content so that
questions and answer options are understood by both the interviewer and the respondent,
2) comprehensive as to the variables being measured, 3) easy to use, 4) time efficient
in terms of administering the tool, scoring patient responses, and applying outcome
data to the patient's treatment plan, and 5) valid and reliable (See Table 1). Useful tools
are constructed in an organized way that will allow data to be analyzed and conclusions
drawn regarding treatment effectiveness.
Finding standardized measurement tools that have the desired characteristics can
be very challenging. Review of the relevant literature revealed a variety of continence
assessment tools as well as recommended content for such tools (Sidani & Woodtli,
1994; Sackett, 1993; USDHHS, AHCPR, 1992; McDowell, 1994; Joseph, 1992; ICSCS, 1990).1,2,3,4,5,6
Unfortunately, none of the tools was sufficiently comprehensive or adaptable to address
the authors' needs, such as serial evaluations of treatment outcomes, so the authors
decided to develop treatment specific measurement tools.
Using information in the literature, ten years of experience with neurourologically
impaired patients and their families, as well as observed and reported signs and
symptoms related to incontinence, a preliminary continence assessment tool was drafted
in 1994. The draft tool was a questionnaire, designed for nurses to use as they interviewed
and examined patients. It also served as a documentation tool. The intent was twofold:
1) to achieve consistency in asking the same questions each time a patient was evaluated,
and 2) to compare current function with past function. The patient's or parent's
answers and comments were written directly on the tool, and the tool was attached
to the patient's medical record.
The draft tool contained the following five categories related to continence: voiding
characteristics; functional independence; sensation level; motivational level; and
bowel characteristics. Each category had 1 to 6 items, for a total of 13 items. Using
a Likert scaling procedure, each item was a specific question related to continence
and was scored as 1 to 6. For example, the question, "What is the degree of
urinary incontinence?" offered the following scoring options: 1) always wet,
2) moderately wet, 3) damp, 4) wet with activity, 5) usually dry, 6) always dry.
The lowest score described the "worst" or "least favorable" function,
and the highest score described the "best" or "most favorable"
function.
Over the next year, the draft tool was used approximately fifty times by three different
Spina Bifida Clinic nurses who were trained to use the tool. The questionnaire was
used to evaluate and document patient progress related to TES therapy. Unfortunately,
more questions than answers were generated when the nurses met as a group to discuss
patient and family responses. Variability in the way questions were asked, for example,
presented inconsistencies in scoring. A lack of clarity within the tool similarly
prevented uniform application and interpretation. The tool was also limited in scope
regarding number of variables addressed. Recognizing that the draft tool's limitations
could potentially compromise measurement outcomes related to the new Continence Program,
the authors decided to seek help from an off-site research agency.
FORGING FORWARD IN TOOL DESIGN
Following the advice of a colleague, the authors contacted Non-Profit Research Consulting
Services (NRCS) in January 1996, and a meeting was arranged. The authors' primary
needs were identified as: 1) statistical analysis of TES data, and 2) improvement
of the draft tool. NRCS was asked to draft an action plan to accomplish what was
needed, with specific activities, time lines, and fees. Based on NRCS's plan, in
February 1996, the authors submitted a proposal to the St. Michael Hospital Foundation
requesting a financial grant to cover NRCS expenses. The request was approved, and
NRCS was contracted to analyze clinical outcome data related to TES, and to facilitate
refinement of the continence assessment tool. Two NRCS consultants worked on the
project. One was an expert in test construction, and the other was a statistician.
The authors worked very closely with the NRCS consultants to facilitate statistical
analysis of the TES data, and to refine the tool. This was accomplished through frequent
mail and facsimile correspondence, extended telephone conversations, and periodic
meetings. (Preliminary outcomes of TES for improved continence have been published
by Balcom, et al.)7
During the ensuing months, the authors concentrated on improving the quality of the
assessment tool by identifying unclear, non-discriminating areas; discussing and
changing wording; expanding categories and items; and by incorporating feedback from
the NRCS consultants. Comments from patients and parents were also helpful. When
the nurses asked the questions from the draft tool, they made notations about which
items were confusing to patients or parents and what their respective ideas were
about removing the confusion. For example, the items addressing stool consistency
and amount needed graphic description before patients and parents could differentiate
answers. Revisiting the literature was also helpful, particularly in deciding how
to further describe and differentiate items to be scored. (O'Brien, Bradford &
Gibb, 1995; Leibold, Braun, Peterson & Col, 1995; Beckman, 1995; Dmochowski,
1996; Ewalt & Bauer, 1996). 8,9.10.11.12
Incorporating the foregoing, the authors continued to revise the tool. The goal was
to have the revised tool ready for the June 1996 Spina Bifida Association of America
(SBAA) Annual Conference. The tool was ready, and had expanded from 5 categories
to 12, and from 12 items to 76. It was comprehensive and tested what the authors
agreed needed to be tested, that is, whether TES was effective to improve continence
outcomes in the myelomeningocele population.
At the 1996 SBAA Conference, members of the SBAA Nursing Council were invited to
critique the Continence Assessment - Nursing Guide for clarity, usefulness,
and completeness. Those who were interested in offering feedback signed a participant
list and received a copy of the assessment tool. The participant list documented
the number of copies that were in circulation and who had them, so that a return
reminder could be sent to a participant if necessary. The following instructions
were printed at the top and far right of each page, "Note: Please write comments
next to the area of concern regarding clarity, usefulness, and completeness."
One-third of the page from top to bottom was left blank for comments. Participants
were provided an addressed, postage prepaid envelope in which to return their responses
to the authors.
To gain broader representation and more feedback, Pediatric Nurse Urology Specialists
who attended the American Academy of Pediatrics' Nurse Affiliate Program in October
1996 were also invited to critique the tool. The authors varied their approach for
this group. Each person who attended the Nurse Affiliate Program received a copy
of the continence assessment tool, accompanied by a cover letter that asked them
to critique the tool. Again, the potential respondents were provided an addressed,
postage prepaid envelope to return their responses.
A total of 35 advance practice nurses (15 from the Spina Bifida Group and 20 from
the Pediatric Urology Group) responded. Many helpful recommendations were offered.
All responses were considered important. The authors met several times to review,
analyze, and synthesize responses for each item. Item content changes were based
on consensus of the authors, guided by the NRCS tool construction consultant. Although
the categories remained the same, most item changes occurred in the way items were
stated.
ESTABLISHING USEFUL TOOLS
Validity and reliability are considered vital elements in establishing the accuracy
of a measure (Lo-Biondo-Wood & Haber, 1994).13 A valid instrument
measures what it purports to measure. Reliability is the consistency with which the
instrument measures the constructs for which it has been created. Inter-rater reliability
is the extent to which two or more independent raters agree in assigning a particular
rating to a particular measure. Internal reliability is also an important dimension
of reliability. It is the extent to which measures are consistent with one another
within the instrument.
Based on the processes used to develop and refine the Continence Assessment -
Nurses Guide (e.g., the literature, extensive experience, expert/advanced practitioners,
instrument design consultants), the authors were confident that the finalized tool
had content validity, a non-statistical type of validity. To verify that the tool
had content validity and to obtain help establishing the tool's reliability, the
authors contacted Research Associates (RA), an independent research and consulting
firm (the NRCS contract had expired). RA was known for its test construction and
research methodology in the areas of health and psychology. After reviewing the instrument,
RA concurred that, because of the methodology used to construct the tool, the finalized
continence assessment tool had adequate content validity. Reliability, however, was
yet unknown.
Between June and September 1997, the principal author met with six nurse raters and
instructed them on how to use the tool. The instruction included: 1) reading through
the tool with the nurses, 2) discussing patient selection, 3) explaining that with
the patient's permission, two nurses would be present during the assessment, but
only one nurse would ask the questions, 4) explaining that the nurses should avoid
discussing which number was circled on the continence assessment tool after the patient
responded to the question, 5) directing the nurses to ask only questions 1.1 - 4.6
and 10.1 - 10.4, for a total of 41 items (the remaining items were either TES specific,
urodynamic/radiographic interpretations, or physical exam findings), and (6) addressing
any remaining concerns the nurses had. Day shift nurses from three separate areas
at St. Michael Hospital - a Spina Bifida Clinic, Sub-Acute Care Unit, and a Rehabilitation
Unit - participated in testing the tool. These areas were selected because the nurses
from those units shared a common interest in outcome measurements related to continence,
patients on their units had incontinence problems, the nurses wanted to participate
in research activities, and because the units ranged from out-patient, to in-patient,
to "in-between." This variety in the experiences of the raters provided
the potential for demonstrating the versatility of the tool. Each test pair consisted
of a Nurse Manager and a Staff Nurse, who were trained to use the tool at the same
time. Each nurse pair was instructed to interview ten patients, using alphabetically
coded photocopies of the tool. Coding the tool was necessary to determine inter-rater
reliability. Although 30 patients yielded a small sample size, it provided an adequate
base upon which to calculate appropriate reliability statistics. Data was forwarded
to RA for statistical analysis.
Data was analyzed using SPSS, a commonly used statistical analysis package (SPSS,
Inc., 1996 ).14 Split half reliability was computed for the entire sample,
using Cronbach Alpha. This was a gross measure for the entire tool. A correlation
coefficient of .93 was obtained. Inter-rater reliability was computed by correlating
the scores of the raters in each nurse pair. Correlation coefficients ranged from
.73 to 1.0, and were considered to reflect a moderately high to high level of reliability
(Satterlee, William, 1997).15
To increase the tool's reliability, clarification between a rating of "5"
(best or most favorable function) and "NA" (not applicable) was advised,
as raters were not consistent in their use of those ratings. The authors appreciated
the advice, and clarification was achieved with a minor revision of the written instructions
for use of the tool. The outcome of this change in improving reliability remains
untested.
CONTINENCE ASSESSMENT NURSES' GUIDE (CAN-GUIDE) EMERGES
The final version of the tool is "Continence Assessment Nurses' Guide"
(CAN-Guide) (Figure 1). The acronym not only applies to the assessment tool, but has significant
implications for the importance nursing practice has in improving the continence
of the patients nurses serve. CAN-Guide is composed of 76 items in 12 categories
related to continence. The 12 categories are: Usual Bladder Patterns, including
degrees of dryness, pads used, and clothing change; Usual Bowel Patterns, including
toileting, evacuation method, and use of laxatives or stool softeners; Habits
Contributing to Independent Self-Care, such as changing pads and clothing;
Dietary Contributions to Bowel Continence, including fiber foods, fluids,
and fiber supplements; Physical Exam Related to TES, such as skin integrity,
bulbocavernous reflex, and rectal tone; Sensory Exam, Somatosensory Evoked
Potentials (SSEPs) to determine baseline and subsequent sensory level, expected to
improve with TES ; Kidney and Bladder Testing, such as renal ultrasound and
voiding cystourethrogram; Urodynamic Studies, including urine testing, cystometrogram,
and urethral pressure profile studies; Motivation Level, including the patient,
parent, and interviewer perspectives; Medications; Summary of Over-All
Progress, again, including the patient, parent, and interviewer perspectives;
and Continence Treatments, which lists the total hours on TES and the number
of Intravesical Bladder Stimulation treatments since the last evaluation (see Table 2).
At first glance, the tool may appear to be too TES specific to have any general value.
A closer look, however, reveals that most of the items can provide useful information
to help any person improve his or her continence. In addition to the 41 broadly applicable
items used to determine inter-rater reliability, motivational levels, radiographic
outcomes, urodynamic findings, compliance with the treatment plan, perceived progress
toward bladder goals, and perceived progress toward bowel goals, together raise the
count to about 50 items relevant to continence assessment. Using the same format,
patient specific item modification could be easily accomplished.
CAN-Guide items are scored using a 1 to 5 scale. One is the least desirable characteristic
(worst function) and 5 is the most desirable characteristic (best function). Each
of the 12 categories is scored independently, listing the highest total score possible
and the patient's score. If an item or items listed in a particular category are
not appropriate for a specific patient, those items can be omitted. For example,
if a patient does not self-catheterize, items 1.4 and 1.5 are omitted, reducing the
composite score from 15 to 13 items in that category. Based on the five point scale,
the patient's total possible points in that category is 65. The patient is queried
about only those items that are pertinent to him or her, and the total possible score
is adjusted accordingly.
The patient's composite score compared to the highest possible score gives the patient
and practitioner data regarding which continence variables to focus on, what goals
to establish, and what interventions need to occur. A score on a single item is not
very useful. Collectively, however, the items in a category do portray patterns of
function. Data from the continence tool may expedite the determination of the most
appropriate treatment plan, which is especially important to the patient. Since the
treatment plan should be evaluated over time, the development of a companion tool
seemed advantageous.
CONTINENCE ASSESSMENT NURSES' OUTCOME RECORD (CANOR)
CAN-Guide has a companion scoring tool called the Continence Assessment Nurses'
Outcome Record (CANOR) (Figure
2). CANOR is used to numerically document outcomes
(responses to treatment) over time. The tool has six columns where data can be entered
on six separate dates. Initial (baseline) data are entered on the tool prior to treatment.
Using this method, the patient serves as his or her own control. As data are entered
at subsequent follow-up evaluations, longitudinal effects of the interventions can
be meaningfully monitored. This can help prevent arbitrary and unnecessary changes
in the treatment plan, as well as form a basis for changes. A systemic record, such
as CANOR, is also an easy way to show progress to the patient - if not in all categories,
at least in some. Some progress is likely to encourage and motivate patients to keep
trying.
As previously stated, CAN-Guide and CANOR were both developed to help better evaluate
continence outcomes related to TES. Patients and their families were initially told
that they would be on TES for two to four years for improved continence. This conveyed
the fact that TES was not a fast process. Patients and families were also told that
because of the newness of the treatment and the lack of published evidence of outcome
effectiveness, they were "pioneers," and that it was possible that no change
would occur. Considering mutual patient, family, and professional goals, if reasonable
progress is not made at the one year point, based on the emerging functional pattern
on CANOR, continuing TES for continence is discouraged.
TES patients are re-evaluated every six months, which includes repeating CAN-Guide
and documenting outcomes on CANOR. CAN-Guide is placed in the patient's chart upon
initial assessment. Thereafter, it is used only to ask the questions and gather data.
The answers are documented in the patient's chart on CANOR. Nurses (the same ones
who were involved with improving the instrument) are now consistent in what they
ask and how they score answers. As new nurses participate, their reliability in this
area will have to be tested.
Three years of data can be tracked on CANOR. This helps practitioners identify functional
trends long before the conclusion of four years of therapy. Regarding TES, these
tools will continue to help better predict: 1) how long it takes for TES to be helpful,
2) how many people TES will actually help, and 3) who the best candidates are for
functional continence improvement, using TES.
TOOL LIMITATIONS
CAN-Guide was carefully developed over a three year time span. While CAN-Guide
is the best tool available to meet the authors' needs in assessing the variables
related to continence, it has limitations. These limitations include the following:
1) small sample size, 2) many items based on subjective reporting, 3) cost constraints
and sample size prevented factor analysis, 4) re-testing the impact of changing the
tool's directions regarding a score of "5" or "NA" remains to
be done, and 5) the tool does not address some adult issues, such as financial impact,
sexuality, and transportation related to incontinence. These limitations can be reduced
as more practitioners use and test CAN-Guide and CANOR.
QUALITY OUTCOMES AND BEYOND
Factors which influence and affect continence are complex. In an effort to add
continuity and strength to our evaluation methods related to TES, a new therapy to
improve continence, the authors sought comprehensive continence assessment tools.
Since those tools found in the literature were inadequate for their needs the authors
decided to develop an original tool. After much time and effort and many rewrites,
as well as help from research and statistical consultants, the Continence Assessment
Nurses' Guide (CAN-Guide) and Continence Assessment Nurses' Outcome Record (CANOR)
were developed. Although many assessment items are subjective in nature because they
are reported by patients and families, the way in which these tools were designed
and the way in which they are used adds objectivity. The authors' outcome measurement
methodology is now strong, valid, and reliable. CAN-Guide and CANOR produce a "quick
look" at the many variables which affect continence, including which areas are
improving and which areas may need treatment modifications.
The authors are excited about the CAN-Guide and CANOR. Beyond meeting their particular
therapy outcome needs, the authors believe these companion tools can contribute to
the assessments and follow-up evaluations performed by many practitioners working
in the continence field. Both patients and practitioners have expressed satisfaction
with the tool when used as a basis for patient feedback and mutual goal planning
related to treatment modalities.
The usefulness of the CAN-Guide and CANOR extend beyond the limits of the neurogenic
bladder and bowel. Because the items on CAN-Guide may be used selectively, the tool
can be applied to most situations involving incontinence. Interested readers are
invited to use and critique the new tool and offer feedback.*
Note: The authors wish to acknowledge the following nurses who participated in
testing CAN-Guide for inter-rater reliability: Connie Bradley, Sheri Katzer, Julie
Shields, Nancy Sonney, Nancy Zoltowski; also, Kimberly Rauen, J.D., for editorial
advice.
*To obtain more information about CAN-Guide and CANOR, please call (414) 527-8556
and ask for Karen Rauen.
![]() |
|
|